Transforming Diabetes Care: GlucosePATH Makes Personalized Medication Recommendations
Release Date: 05/29/2024
In the News... Omnipod 5 iPhone update, Libre & Dexcom news, overnight insulin pump and more!
Diabetes Connections Type 2
It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: iPhone control for Omnipod 5 rolls out, Libre is approved for use in CT scans and MRIs, Dexcom files for 15 day wear, Luna nighttime pump goes to trial, iLet cell trials move forward and more! Find out more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures Learn more about Drive The best way to keep up with Stacey and the show is by signing up for our weekly...
info_outline
In the News... Hurricane aid, Medtronic safety warning, Mounjaro supply update, stem cell T1D success... and more!
Diabetes Connections Type 2
It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Hurricane aid for people with diabetes, Medtronic safety warning, stem cell updates for type 1, new study about teens and young adults with type 1, and Ryan Reed returns to racing. Find out more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures Learn more about Drive The best way to keep up with Stacey and the show is by signing up for our weekly newsletter:...
info_outline
In the News... Insulin price lawsuit, new CGM approved, diabetes camp scholarships... and more!
Diabetes Connections Type 2
It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: The FTC sues PBMs over insulin pricing, a new CGM is approved in Europe, more news about GLP-1s but some research says it may not work as well for one population, diabetes camps are invited to apply for grants, and more! Find out more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures Learn more about Drive The best way to keep up with Stacey and the show is by...
info_outline
Omnipod 5 Brings Automated Insulin Delivery to Type 2 Diabetes
Diabetes Connections Type 2
Automated insulin delivery has been an incredible advancement for insulin pumps. Now, for the first time, the FDA has approved a system for people with type 2. It’s called Omnipod 5. We’re going to talk about how it works, who it helps, and what the company found in their studies of people who use it. My guest this week is Dr. Trang Ly, truly one of the pioneers of studying and innovating around automated insulin delivery – or AID – systems. She is the Medical Director at Insulet, the company that makes Omnipod. Prior to joining Insulet, Dr. Ly served as Clinical Assistant...
info_outline
CGM Without a Prescription: Stelo & the Future of Diabetes Care with Dexcom's Jake Leach
Diabetes Connections Type 2
For the first time, you can buy a continuous glucose monitor over the counter, no prescription needed. This summer we went from no CGMs available this way, to now having two. This week we’re talking about the Dexcom Stelo with the company’s COO Jake Leach. We’ll go through the features, the price, how to order and what you should know before you start a CGM. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. More Our Please visit our Sponsors & Partners - they help make the show possible! Check...
info_outline
In the News... CGM in space, diet and type 1 diabetes study, GLP-1 gel in development, and more!
Diabetes Connections Type 2
It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: Dexcom CGM is worn in space, two over-the-counter CGMs are now available, a large new study looks at potential dietary causes of type 1, and researchers are looking at a gel version of GLP-1 medications. Find out more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures Learn more about Drive The best way to keep up with Stacey and the show is by signing up for our...
info_outline
In the News.. Omnipod 5 approved for type 2, bright light at night diabetes link, Zepbound price cut, and more!
Diabetes Connections Type 2
It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: The FDA approved Omnipod 5 for people with type 2 who use insulin, Dexcom's Stelo, the first over the counter CGM, is now on sale. more evidence that bright light at night may increase the risk of diabetes, a price cut for Zepbound, and more! Find out more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures Learn more about Drive The best way to keep up with...
info_outline
In the News... weekly basal + semaglutide, liver targeted insulin, Lance Bass educates about LADA, and more!
Diabetes Connections Type 2
It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: A weekly basal plus semaglutide is in the works, but not for the US right now, Tandem updates it's app recall, liver targeted insulin study, a weird walking story, and Lance Bass educates about LADA. Find out more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures Learn more about Drive The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Here's where to...
info_outline
Preventing kidney complications: Information over fear
Diabetes Connections Type 2
Talking about any possible complications from diabetes can be scary – and most of us only think of kidney issues in the worst possible way: transplant and dialysis. But there’s a lot you can do to stay healthy and there’s news from just this summer about how new medications are making a big difference to reduce your risk. My guests this week are Dr. Bob Gabbay, Chief Scientific and Medical Officer, American Diabetes Association and Dr. Jeff Giullian, Chief Medical Officer of DaVita. DaVita Kidney Care is a leading provider of kidney care in the United States. This podcast is not intended...
info_outline
In the News...Does insulin use differ by gender? Diabetes & Covid update, fully implantable CGM studied, and more!
Diabetes Connections Type 2
It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: A new study looks at insulin needs in men vs women, updates on stem cell transplants and a new look at COVID 19 and T1D plus a fully implantable CGM is announced. We'll also tell you about a T1D athlete drafted to the MLB. Lots more in this week's episode, full transcipt below. Find out more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures Learn more about Drive The best way to keep up with...
info_outlineGlucosePATH uses computer science and clinical data to evaluate every possible treatment option, using data from the patient, FDA, and peer-reviewed journals, in just a few seconds. It was created by computer scientist Len Testa and endocrinologist Dr. Bradly Eilerman.
Len Testa is also co host of the fabulous Disney Dish podcast and the creator of Touring Plans the app and service of The Unofficial Guides to Walt Disney World, Disneyland and Disney Cruise Line. Testa is all about the math of theme parks – his guides are there to maximize the magic as he says – to make your waits shorter and save money – and it’s all based on calculations from his team.
Disney very recently made some changes to their Disability Access Services program – often referred to as a DAS pass at Disney World and Disney Land. We’re going to talk about why this happened, what it means for you, and what else is going on at Disney.
Note: this interview was taped BEFORE the changes took place.
More about Len Testa's Touring Plans here
More about the DAS changes here
We’re also spending some time talking about a new service for doctors called Glucosepath and about a new surprising study about cortisol and diabetes. I’ll also explain how these two guests can talk about all of these issues..
Dr. Eilerman also talks about the Catalyst study which looks at people with type 2 diabetes and measures cortisol.
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
Please visit our Sponsors & Partners - they help make the show possible!
Check out US MED
Find out more about CeQur Simplicity
Check out VIVI Cap to protect your insulin from extreme temperatures
Learn more about AG1 from Athletic Greens
--
We have a monthly newsletter! Sign up today (no spam we promise)
Here's where to find us:
YouTube (new!)
Learn more about everything at our home page www.diabetes-connections.com
Reach out with questions or comments: [email protected]